COVID-19

Maladies autoimmunes et Thérapie cellulaire – Covid-19 et Thérapie cellulaire


Les références en gras ont été publiées par les membres de MATHEC
Les références en italique ont pour sujet les cellules stromales mésenchymateuses

2023

SARS-CoV-2-infection in the setting of autotransplants for multiple sclerosis
Olivares-Gazca JC, Gale RP, Sánchez-Bonilla D, Gallardo-Pérez MM, Soto-Olvera S, Ruiz-Delgado GJ,
Ruiz-Argüelles GJ
Hematology 10 Jan 2023, Vol. 28, NO. 1, 2164443
https://doi.org/10.1080/16078454.2022.2164443

Lower incidence but higher mortality in COVID-19 hospitalizations among systemic sclerosis patients
Patel S, Patel S, Shah S, Lio PA
JAAD International 7 Jan 2023, Vol. 28, NO. 1, 2164443
https://doi.org/10.1080/16078454.2022.2164443

2022

Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial
Grégoire C, Layios N, Lambermont B, Lechanteur B, Briquet A, Bettonville V, Baudoux E, Thys M, Dardenne M, Misset B, Beguin Y
Front. Immunol., 04 July 2022;Sec. Alloimmunity and Transplantation
https://doi.org/10.3389/fimmu.2022.932360

Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey
Passweg JR, Baldomero H, Chabannon C, Corbacioglu S, de la Cámara R, Dolstra H, Glass B, Greco R, Mohty M, Neven B, Peffault de Latour R, Perić Z, Snowden J A, Yakoub-Agha I, Sureda A, Kröger N, European Society for Blood and Marrow Transplantation (EBMT)
Bone Marrow Transplant. 2022 May;57(5):742-752.
doi: 10.1038/s41409-022-01604-x. Epub 2022 Feb 22.

Mesenchymal stem cell treatment for COVID-19
Xu R, Feng Z,and Wang F-S
EBioMedicine. 2022 Mar;77:103920.doi: 10.1016/j.ebiom.2022.103920. Epub 2022 Mar 10.

Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
Chen L, Qu J, Kalyani FS, Zhang Q, Fan L, Fang Y, Li Y, Xiang C
Cell Mol Life Sci. 2022 Feb 20;79(3):142.doi: 10.1007/s00018-021-04096-y.

COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune disease
Alsuliman T, Stocker N, Van de Wyngaert Z, Ikhlef S,Ellouz C,Corre E,Banet A, Ricard L,Dulery R,Meynard JL,Malard F, Stankoff B,Farge-Bancel D,Brissot E,Mohty M,Marjanovic Z.
Curr Res TranslMed.2022May;70(2):103332.doi:10.1016/j.retram.2021.103332. Epub 2021 Dec 24.

2021

SARS-COV-2 vaccination after stem cell transplantation for scleroderma
Rimar D, Slobodin G, Paz A, Henig I, Zuckerman T
Ann Rheum Dis. 2021 Oct;80(10):1354-1355.doi: 10.1136/annrheumdis-2021-220677.

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
Greco R, Alexander T, Burman J, Del Papa N, de Vries-Bouwstra J, Farge D, Henes J, Kazmi M, Kirgizov K, Muraro P A, Ricart E, Rovira M, Saccardi R, Sharrack B, Snarski E, Withers B, Jessop H, Boglione C, Kramer E, Badoglio M, Labopin M, Orchard K, Corbacioglu S, Ljungman P, Mikulska M, De la Camara R, Snowden J A, European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), Infectious Diseases Working Party (IDWP), Pediatric Working Party (PWP), Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE), EBMT Nurses Group and Patient Advocacy Committee
Bone Marrow Transplant. 2021 Jul;56(7):1493-1508.doi: 10.1038/s41409-021-01326-6. Epub 2021 May 24.

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
Greco R, Alexander T, Burman J, Del Papa N, de Vries-Bouwstra J, Farge D, Henes J, Kazmi M, Kirgizov K, Muraro PA, Ricart E, Rovira M, Saccardi R, Sharrack B, Snarski E, Withers B, Jessop H, Boglione C, Kramer E, Badoglio M, Labopin M, Orchard K, Corbacioglu S, Ljungman P, Mikulska M, De la Camara R,Snowden JA, European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), Infectious Diseases Working Party (IDWP), Pediatric Working Party (PWP), Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE), EBMT Nurses Group and Patient Advocacy Committee
Bone Marrow Transplant. 2021 May 24;1-16.doi: 10.1038/s41409-021-01326-6.

Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS‐CoV‐2 infections
Avanzini MA, Mura M, Percivalle E, Bastaroli F, Croce F, Valsecchi C, Lenta E, Nykjaer G, Cassaniti I, Bagnarino J, Baldanti F, Zecca M, Comoli P, Gnecchi M
Stem Cells Transl Med. 2021 Apr; 10(4): 636–642. Published online 2021 Jan 26. doi: 10.1002/sctm.20-0385

2020

COVID-19 vaccines. Version 2.0 December 21, 2020
Prepared by: Per Ljungman, Simone Cesaro, Catherine Cordonnier, Malgorzata Mikulska, Jan Styczynski, Rafael de la Camara.
Approved by: Nicolaus Kröger, John Snowden, Harry Dolstra, Andreu Gusi

Coronavirus Disease COVID-19: EBMT Recommendations – VERSION 13
Prepared by: Per Ljungman, Jan Styczynski, Malgorzata Mikulska, Rafael dela Camara
Approved by: Nicolaus Kröger, John Snowden, Harry Dolstra, Andreu Gus

Coronavirus disease 2019: A tissue engineering and regenerative medicine perspective
Shafiee A, Moradi L, Lim M, Brown J
STEM CELLS Transl Med. 2020;1–12.